NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ) today announced that its Enzo Clinical Labs subsidiary has strengthened its senior management team with the appointment of Kevin Krenitsky, M.D., as President. Krenitsky is a highly respected 12-year veteran of the life sciences industry, bringing a wealth of experience in building and managing global diagnostic operations.
